JP2007534751A5 - - Google Patents

Download PDF

Info

Publication number
JP2007534751A5
JP2007534751A5 JP2007510716A JP2007510716A JP2007534751A5 JP 2007534751 A5 JP2007534751 A5 JP 2007534751A5 JP 2007510716 A JP2007510716 A JP 2007510716A JP 2007510716 A JP2007510716 A JP 2007510716A JP 2007534751 A5 JP2007534751 A5 JP 2007534751A5
Authority
JP
Japan
Prior art keywords
equol
skin
composition
hair
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007510716A
Other languages
English (en)
Japanese (ja)
Other versions
JP5220406B2 (ja
JP2007534751A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/004997 external-priority patent/WO2005107770A1/en
Publication of JP2007534751A publication Critical patent/JP2007534751A/ja
Publication of JP2007534751A5 publication Critical patent/JP2007534751A5/ja
Application granted granted Critical
Publication of JP5220406B2 publication Critical patent/JP5220406B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007510716A 2004-04-28 2005-02-17 皮膚疾患を処置するためのエクオールの使用 Expired - Lifetime JP5220406B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52145704P 2004-04-28 2004-04-28
US60/521,457 2004-04-28
PCT/US2005/004997 WO2005107770A1 (en) 2004-04-28 2005-02-17 Use of equol for treating skin diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012222148A Division JP2013006874A (ja) 2004-04-28 2012-10-04 皮膚疾患を処置するためのエクオールの使用

Publications (3)

Publication Number Publication Date
JP2007534751A JP2007534751A (ja) 2007-11-29
JP2007534751A5 true JP2007534751A5 (https=) 2008-03-27
JP5220406B2 JP5220406B2 (ja) 2013-06-26

Family

ID=35320034

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007510716A Expired - Lifetime JP5220406B2 (ja) 2004-04-28 2005-02-17 皮膚疾患を処置するためのエクオールの使用
JP2012222148A Withdrawn JP2013006874A (ja) 2004-04-28 2012-10-04 皮膚疾患を処置するためのエクオールの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012222148A Withdrawn JP2013006874A (ja) 2004-04-28 2012-10-04 皮膚疾患を処置するためのエクオールの使用

Country Status (6)

Country Link
US (1) US20050245492A1 (https=)
EP (2) EP1740191A4 (https=)
JP (2) JP5220406B2 (https=)
AU (1) AU2005239984B2 (https=)
CA (1) CA2564399A1 (https=)
WO (1) WO2005107770A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
CA2504682A1 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
US20080108696A1 (en) * 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
CA2660056A1 (en) * 2006-08-18 2008-02-21 Colorado State University Research Foundation Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
US8147759B2 (en) 2007-08-29 2012-04-03 Cem Corporation Automated protein analyzer
US8852948B2 (en) * 2007-08-29 2014-10-07 Cem Corporation Colorimetric protein analysis method
JP5968590B2 (ja) * 2007-11-05 2016-08-10 ケーシーアイ ライセンシング インコーポレイテッド 創面切除のための組織の同定
US20090222281A1 (en) * 2008-03-03 2009-09-03 Vibhuti Uppal Formulation for multi-step acne treatment
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
CA2771389C (en) 2009-08-21 2019-04-09 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
JP2013515054A (ja) 2009-12-22 2013-05-02 エイボン プロダクツ インコーポレーテッド パキシリン刺激組成物及びその化粧品としての使用
WO2011149595A1 (en) 2010-05-28 2011-12-01 Nexgen Dermatologics, Inc. Combination therapy for skin disorders
US8591876B2 (en) * 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
CN102764253B (zh) * 2012-07-16 2014-03-05 上海交通大学 苯并吡喃生物碱的应用
JP2017531025A (ja) * 2014-10-14 2017-10-19 ジャクソン，リチャード・エル Ｓ−エクオールの無水結晶形
JP7068816B2 (ja) * 2017-12-15 2022-05-17 大塚製薬株式会社 エクオールおよびコラーゲンペプチドを含有する経口組成物
WO2019240872A1 (en) * 2018-06-15 2019-12-19 The Board Of Regents Of The University Of Texas System Methods of treating and preventing melanoma with s-equol
AU2019285640A1 (en) 2018-06-15 2021-01-21 Board Of Regents Of The University Of Texas System Methods of treating and preventing breast cancer with S-equol
JP7596493B1 (ja) * 2023-11-24 2024-12-09 株式会社ダイセル 男性のｑｏｌの改善のための組成物

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390559A (en) * 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US5468501A (en) 1982-09-01 1995-11-21 Hercon Laboratories Corporation Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant
USRE34457E (en) * 1983-12-28 1993-11-30 Daicel Chemical Industries, Inc. Separating agent
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
CH679584A5 (https=) * 1989-11-10 1992-03-13 Nestle Sa
TW279133B (https=) 1990-12-13 1996-06-21 Elan Med Tech
DE69333624T2 (de) * 1992-05-19 2005-09-15 Novogen Research Pty. Ltd., North Ryde Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
US5436007A (en) 1992-10-23 1995-07-25 Abbott Laboratories Diaper rash lotion
CA2160371A1 (en) * 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
US5613958A (en) 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5320949A (en) * 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
US5424331A (en) * 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5523087A (en) * 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
CA2222133C (en) 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US5693018A (en) 1995-10-11 1997-12-02 Science Incorporated Subdermal delivery device
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5726034A (en) * 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US5804234A (en) * 1996-09-13 1998-09-08 Suh; John D. Plant protein for nutritional products and method of making same
US6020471A (en) * 1996-09-13 2000-02-01 Abbott Laboratories Process for isolating phytoestrogens from plant protein
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
AUPO427196A0 (en) * 1996-12-19 1997-01-23 University Of Sydney, The A method for preventing or controlling cataract
US6146668A (en) * 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
WO1998050026A1 (en) * 1997-05-01 1998-11-12 Novogen Inc Treatment or prevention of menopausal symptoms and osteoporosis
US6083526A (en) * 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
DE69832516T2 (de) * 1997-08-08 2006-07-27 Otsuka Pharmaceutical Co., Ltd. Isoflavon-enthaltende zusammensetzungen
US6521433B1 (en) * 1997-09-17 2003-02-18 E. I. Du Pont De Nemours And Company cDNA sequences from plants that encode activities associated with isoflavone biosynthesis
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5952374A (en) * 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US5942539A (en) * 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6004558A (en) * 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
BR9906998A (pt) * 1998-09-10 2000-09-26 Avon Prod Inc Método e composições para reduzir o envelhecimento dermatológico e para reduzir contusões
WO2000030664A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
EE200100526A (et) * 1999-04-16 2002-12-16 Astrazeneca Ab Östrogeeni ß-retseptori ligandid
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
US6375994B1 (en) * 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
DE10100586C1 (de) 2001-01-09 2002-04-11 Ribopharma Ag Verfahren zur Hemmung der Expression eines Ziegens
EP1414436A1 (en) * 2000-06-14 2004-05-06 Alla Shapiro Radioprotective agents
US6455568B2 (en) * 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
US6326366B1 (en) * 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
US6565864B2 (en) * 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
EP1234572B1 (de) * 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
US6638543B2 (en) * 2001-02-27 2003-10-28 Regents Of The University Of Michigan Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor
DE10121375B4 (de) * 2001-05-02 2014-01-16 Beiersdorf Ag Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut
FR2825277B1 (fr) * 2001-05-30 2004-10-15 Oreal Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd
US6597597B2 (en) * 2001-11-13 2003-07-22 Hewlett-Packard Company Low temperature attaching process for MRAM components
EP1545206B1 (en) * 2002-07-24 2020-03-04 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
US20060153782A1 (en) * 2002-09-23 2006-07-13 Novogen Research Pty Ltd Skin photoageing and actinic damage treatment
CA2504682A1 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases

Similar Documents

Publication Publication Date Title
JP2007534751A5 (https=)
US5962505A (en) Method for treating hot flashes in humans
JP2005518359A (ja) フェニル−グリシン誘導体を含む組成物
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
CA2564399A1 (en) Use of equol for treating skin diseases
KR101205209B1 (ko) 탈모방지 및 발모촉진용 외용제 조성물
JP2006508942A5 (https=)
CN103520328B (zh) 一种复方中药痤疮凝胶及其制备方法
CN103070804B (zh) 祛痘净肤液
CN105193672A (zh) 一种细胞再生元修复精华液及其制备方法
CA3127175C (en) Use of topical braf inhibitor compositions for treatment of radiation dermatitis
AU762126B2 (en) Method for treating hot flashes in humans
CN102764256A (zh) 一种治疗痤疮的药膏
CN108635511A (zh) 白芍和铁皮石斛在制备治疗高血压药物中的应用方法
US20060115503A1 (en) Composition, system and method for treatment of skin
CN105497537A (zh) 一种具有美白嫩肤作用的药物组合物及其制备方法
JP2016501236A (ja) 炎症性皮膚状態の予防および治療のための方法
CA2809793C (en) Treatment of fungal infections
CN108743460A (zh) 一种治疗黄褐斑的消斑精油
WO2010049462A1 (en) Depigmenting topical compositions and their uses
JP2004502634A5 (https=)
WO2001003325A2 (de) Verwendung von kreatin und/oder kreatin-derivaten zur behandlung von befindlichkeitsstörungen bei frauen
JP2023077696A (ja) 尋常性ざ瘡改善剤
CN118340832A (zh) 一种用于疤痕修补的中药凝胶
Newaj What to do about hyperpigmentation?